Today, Congressman Jerrold Nadler (NY-12) announced over $9 million in combined grant funding from the US Department of Health and Human Services (HHS) to health care institutions in New York’s 12th Congressional District.
 
“The East Side is home to a number of the finest hospitals and medical universities in the world,” said Congressman Nadler. “I’m proud to announce this funding which will help these institutions continue their legacy of innovation in medical scientific research, particularly in the fields of cancer, diabetes, and mental health treatment. The grants HHS delivers today will fund the discoveries that will save lives tomorrow.”

As of February 1st, 2024, $9,097,806 in total HHS grant funding has been delivered to the following institutions:

$4,735,906 for Memorial Sloan Kettering Cancer Center

$2,757,067 for Weill Cornell Medicine

$1,604,833 for NYU Grossman School of Medicine
 
Dr. Robert A. Harrington, Stephen and Suzanne Weiss Dean of Weill Cornell Medicine and provost for medical affairs of Cornell University, said: "At Weill Cornell Medicine, we are proud of the innovative and transformational research that is designed to save lives and improve the health of the communities we serve. Congressman Nadler and his colleagues in Washington have done tremendous work, in a bipartisan fashion, to provide the NIH and other federal research agencies the investments needed to fuel the discoveries of tomorrow. The continuation of such bipartisan support and enthusiasm for research in health and medicine is needed now more than ever."

Steve Ritea, New York University Grossman School of Medicine spokesperson said: "This important funding helps NYU Langone Health and the NYU Grossman School of Medicine continue to pioneer the medical breakthroughs that provide hope and healing for all. Our community is grateful for the Congressman's continued support for biomedical research that has the potential to transform lives and shape the future of medicine."

Memorial Sloan Kettering Cancer Center said: “Scientific research is critical to MSK’s mission and our efforts to make meaningful strides against cancer. We thank Congressman Nadler for his continued and steadfast support of the National Institutes of Health (NIH) whose federal investment in medical research is crucial to our nations’ health.” 

###